Yongling Ning - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Yongling Ning

Showing results (11-20 of 15) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 15 results.

Journal for Immunotherapy of Cancer|June 20, 2020

HDAC9 deficiency promotes tumor progression by decreasing the CD8+ dendritic cell infiltration of the tumor microenvironmentYongling Ning, Jun Ding, Xiao Sun, et al.

Frontiers in Pharmacology|May 13, 2022

β-Glucan Combined With PD-1/PD-L1 Checkpoint Blockade for Immunotherapy in Patients With Advanced CancerMengjie Wang, Yu Bai, Jiaxin Pei, et al.

International Journal of Cancer|January 17, 2016

β-glucan restores tumor-educated dendritic cell maturation to enhance antitumor immune responsesYongling Ning, Dongqin Xu, Xiaohang Zhang, et al.

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 4, 2015

MiR-124 inhibits cell proliferation in breast cancer through downregulation of CDK4Tongbao Feng, Dongqin Xu, Chao Tu, et al.

Frontiers in Pharmacology|January 30, 2023

Whole β-glucan particle attenuates AOM/DSS-induced colorectal tumorigenesis in mice via inhibition of intestinal inflammationYewen Xie, Fang Shao, Xuehan Duan, et al.

Pageof 2

Search research articles

Showing results (11-20 of 15) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 15 results.

Journal for Immunotherapy of Cancer|June 20, 2020

HDAC9 deficiency promotes tumor progression by decreasing the CD8+ dendritic cell infiltration of the tumor microenvironmentYongling Ning, Jun Ding, Xiao Sun, et al.

Frontiers in Pharmacology|May 13, 2022

β-Glucan Combined With PD-1/PD-L1 Checkpoint Blockade for Immunotherapy in Patients With Advanced CancerMengjie Wang, Yu Bai, Jiaxin Pei, et al.

International Journal of Cancer|January 17, 2016

β-glucan restores tumor-educated dendritic cell maturation to enhance antitumor immune responsesYongling Ning, Dongqin Xu, Xiaohang Zhang, et al.

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 4, 2015

MiR-124 inhibits cell proliferation in breast cancer through downregulation of CDK4Tongbao Feng, Dongqin Xu, Chao Tu, et al.

Frontiers in Pharmacology|January 30, 2023

Whole β-glucan particle attenuates AOM/DSS-induced colorectal tumorigenesis in mice via inhibition of intestinal inflammationYewen Xie, Fang Shao, Xuehan Duan, et al.

Pageof 2